|
Synonyms: asparaginase | Elspar® | Enrylaze® | L-asparaginase | L-asparagine amidohydrolase
crisantaspase is an approved drug (FDA (no history prior to 2011), EMA (2023))
Compound class:
Peptide
Comment: Crisantaspase is a chemotherapy agent. The asparaginase enzyme can be isolated from Erwinia chrysanthemi or Escherichia coli. The two forms have different immunogenicity profiles. The amino acid sequence shown here is for the Erwina isoform, crisantaspase.
|
Classification  |
|
| Compound class | Peptide |
| Approved drug? | Yes. FDA (2011) |
| WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
| International Nonproprietary Names |
|
| INN number | INN |
| 9538 | crisantaspase |
| Synonyms |
| asparaginase | Elspar® | Enrylaze® | L-asparaginase | L-asparagine amidohydrolase |
| Database Links |
|
| CAS Registry No. | 9015-68-3 (source: Scifinder) |
| DrugBank Ligand | DB00023 |
| GtoPdb PubChem SID | 178103919 |
| Search PubMed clinical trials | crisantaspase |
| Search PubMed titles | crisantaspase |
| Search PubMed titles/abstracts | crisantaspase |
| Wikipedia | Asparaginase |
